AA
EW icon

AlphaMark Advisors’s Edwards Lifesciences EW Stock Holding History

AlphaMark Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.31M Buy
17,740
+201
+1% +$14.1K 0.57% 39
2024
Q3 		$1.16M Sell
17,539
-1,191
-6% -$86.5K 0.4% 46
2024
Q2 		$1.73M Buy
+18,730
New +$1.66M 0.6% 31
2023
Q4 		– Sell
-21,381
Closed -$1.48M – 737
2023
Q3 		$1.48M Buy
+21,381
New +$1.72M 0.63% 33
2023
Q2 		– Sell
-26,935
Closed -$2.23M – 627
2023
Q1 		$2.23M Buy
26,935
+717
+3% +$56.4K 1% 24
2022
Q4 		$1.96M Buy
+26,218
New +$2.02M 0.98% 25
2022
Q3 		– Sell
-60
Closed -$6K – 702
2022
Q2 		$6K Buy
+60
New +$6.21K ﹤0.01% 449
2021
Q3 		– Sell
-60
Closed -$6K – 586
2021
Q2 		$6K Hold
60
– – ﹤0.01% 440
2021
Q1 		$5K Sell
60
-50
-45% -$4.23K ﹤0.01% 436
2020
Q4 		$10K Buy
+110
New +$9.12K ﹤0.01% 362
2020
Q2 		– Sell
-150
Closed -$9K – 565
2020
Q1 		$9K Buy
+150
New +$10.8K 0.01% 311
2019
Q3 		– Sell
-120
Closed -$7K – 492
2019
Q2 		$7K Hold
120
– – ﹤0.01% 372
2019
Q1 		$8K Sell
120
-510
-81% -$29.1K ﹤0.01% 343
2018
Q4 		$32K Buy
630
+465
+282% +$23.5K 0.02% 214
2018
Q3 		$10K Hold
165
– – ﹤0.01% 341
2018
Q2 		$8K Hold
165
– – ﹤0.01% 384
2018
Q1 		$8K Buy
+165
New +$7.17K ﹤0.01% 365

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AlphaMark Advisors's EW Position: Q4 2024 in Review

AlphaMark Advisors increased its Edwards Lifesciences (EW) stake by 1.1% in Q4 2024, buying an estimated $14.1K and bringing the position to 17,740 shares worth $1.31M. The position accounts for 0.57% of the portfolio, ranked #39.

AlphaMark Advisors first reported a position in EW in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.23M in Q1 2023. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • AlphaMark Advisors held 17,740 shares of Edwards Lifesciences worth $1.31M as of Q4 2024.
  • AlphaMark Advisors bought 201 Edwards Lifesciences shares in Q4 2024, an estimated $14.1K.
  • Edwards Lifesciences made up 0.57% of AlphaMark Advisors's portfolio in Q4 2024, its #39 holding.
  • AlphaMark Advisors first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 17 quarters since.
  • AlphaMark Advisors's Edwards Lifesciences position peaked at $2.23M in Q1 2023.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.